Hervé J Brisse, M Beth McCarville, Claudio Granata, K Barbara Krug, Sandra L Wootton-Gorges, Kimio Kanegawa, Francesco Giammarile, Matthias Schmidt, Barry L Shulkin, Katherine K Matthay, Valerie J Lewington, Sabine Sarnacki, Barbara Hero, Michio Kaneko, Wendy B London, Andrew D J Pearson, Susan L Cohn, Tom Monclair
Neuroblastoma is an enigmatic disease entity; some tumors disappear spontaneously without any therapy, while others progress with a fatal outcome despite the implementation of maximal modern therapy. However, strong prognostic factors can accurately predict whether children have "good" or "bad" disease at diagnosis, and the clinical stage is currently the most significant and clinically relevant prognostic factor. Therefore, for an individual patient, proper staging is of paramount importance for risk assessment and selection of optimal treatment...
October 2011: Radiology